Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LY4515100 in Acute Postsurgical Pain After Third Molar Removal
NCT07511816Phase 2Recruiting
- Sponsor
- Eli Lilly and Company
- Start
- Apr 2026
- Primary completion
- Nov 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of LY4515100 in acute pain, sponsored by Eli Lilly and Company. Started Apr 2026; status: recruiting.
02
Drugs
LY4515100
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT07511816.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07511816.